Validation Institute Announces Program Validation Achievement
WOBURN, Mass., August 3, 2023 /PRNewswire-PRWeb/ -- Acacia Mental Health ("Acacia"), the leader in rapid, medication-free treatment of depression and anxiety, announced that it has achieved the prestigious Program Validation from Validation Institute for its BRAIN™ protocol. The Program Validation delivers unmatched cost reductions and better outcomes for treatment-resistant Obsessive Compulsive Disorder (OCD). Per the independent analysis, the BRAIN™ protocol is cost-effective in addressing treatment-resistant obsessive-compulsive disorder, with remission rates >30%. Further, 58% have a meaningful response.
- Acacia Mental Health ("Acacia"), the leader in rapid, medication-free treatment of depression and anxiety, announced that it has achieved the prestigious Program Validation from Validation Institute for its BRAIN™ protocol.
- WOBURN, Mass., August 3, 2023 /PRNewswire-PRWeb/ -- Acacia Mental Health ("Acacia"), the leader in rapid, medication-free treatment of depression and anxiety, announced that it has achieved the prestigious Program Validation from Validation Institute for its BRAIN™ protocol.
- The Program Validation delivers unmatched cost reductions and better outcomes for treatment-resistant Obsessive Compulsive Disorder (OCD).
- Validation Institute confers Program-Level Validation only for vendors whose savings or outcomes are backed by actual double-blinded trials rather than participants-vs-non-participants or other methodologies.